hepatitis drug

Zydus Cadila seeks DCGI nod for use of hepatitis drug for COVID-19 treatment

Phase-III clinical trials with Pegylated Interferon Alpha 2b, which company sells under the brand name 'PegiHep' has shown promising results in treati